ACUTE LEUKEMIA OF AMBIGUOUS LINEAGE IN RELAPSE

Clinical trials for ACUTE LEUKEMIA OF AMBIGUOUS LINEAGE IN RELAPSE explained in plain language.

Never miss a new study

Get alerted when new ACUTE LEUKEMIA OF AMBIGUOUS LINEAGE IN RELAPSE trials appear

Sign up with your email to follow new studies for ACUTE LEUKEMIA OF AMBIGUOUS LINEAGE IN RELAPSE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 1

New drug combo tested in kids with Tough-to-Treat leukemia

Disease control Recruiting now

This early-stage study aims to find the safest and most effective dose of a drug called venetoclax when given alongside standard chemotherapy. It is for children, teens, and young adults up to age 40 with high-risk blood cancers like leukemia and myelodysplastic syndrome (MDS) th…

Matched conditions: ACUTE LEUKEMIA OF AMBIGUOUS LINEAGE IN RELAPSE

Phase: PHASE1 • Sponsor: Andrew E. Place, MD • Aim: Disease control

Last updated Apr 01, 2026 14:42 UTC

ACUTE LEUKEMIA OF AMBIGUOUS LINEAGE IN RELAPSE

Get alerted when new ACUTE LEUKEMIA OF AMBIGUOUS LINEAGE IN RELAPSE trials appear

New drug combo tested in kids with Tough-to-Treat leukemia